Cite
HARVARD Citation
Sallmon, H. et al. (2019). Vascular endothelial growth factor polymorphism rs2010963 status does not affect patent ductus arteriosus incidence or cyclooxygenase inhibitor treatment success in preterm infants. Cardiology in the young. pp. 893-897. [Online].